Seragon Pharmaceuticals
Develops small-molecule drugs for the treatment of estrogen receptor dependent breast cancer. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
AUD185—278m (Dealroom.co estimates Oct 2013.)
Irvine California (HQ)
Authorizing premium user...